Dominik is a founding partner of BB Pureos Bioventures. He is also President of the Swiss Biotech Association and a co-founder and Executive Chairman of CDR-Life. Previously, he was a founder and chief executive officer of ESBATech, which was acquired in 2009 by Alcon (Novartis) for $589 million (USD). As a biotech entrepreneur, he raised $90 million (USD) for ESBATech to develop novel antibody fragments, from discovery to clinical proof-of-concept, delivering multiple clinically successful products (eg, Beovu). Dominik earned his PhD in molecular biology from the University of Zurich and holds a master’s degree in education, with specialization in management and organization from ETH Zürich.
This person is not in the org chart
This person is not in any teams
This person is not in any offices